At the core of Parkinson’s disease lies a fundamental neurological change, the gradual loss of dopamine-producing neurons in the brain. Dopamine is a critical chemical messenger that plays a central role in coordinating movement, regulating mood, and enabling smooth communication between different parts of the brain. When dopamine levels decline, the body’s ability to control movement becomes increasingly affected.
In a healthy brain, dopamine helps transmit signals between the substantia nigra, a region deep within the brain and other areas responsible for motor control. This communication ensures that movements are smooth, balanced, and well-coordinated. However, in Parkinson’s disease, the cells responsible for producing dopamine begin to deteriorate over time. By the time noticeable symptoms appear, a significant percentage of these cells may already be lost.
This reduction in dopamine disrupts the brain’s signalling system, leading to the hallmark motor symptoms of Parkinson’s. Tremors, particularly at rest, are among the most recognised signs. However, other symptoms such as bradykinesia (slowness of movement), muscle rigidity, and impaired balance are equally significant. Everyday actions like walking, writing, or even facial expressions can become slower and less fluid.
For your daily dose of medical news and updates, visit: HEALTH
Beyond movement, dopamine loss also impacts other functions. Since dopamine is involved in reward, motivation, and emotional regulation, its decline can contribute to mood disorders such as depression and anxiety. Cognitive changes, including difficulties with attention and decision-making, may also emerge over time.
What makes Parkinson’s particularly complex is that dopamine loss is gradual and varies from person to person. Some individuals may experience mild symptoms for years, while others may see faster progression. This variability underscores the importance of early recognition and personalised care.
While dopamine loss cannot currently be reversed, medical treatments aim to manage its effects. Medications such as Levodopa work by replenishing dopamine levels or mimicking its action in the brain, helping to improve movement and reduce symptoms. In some cases, advanced treatments like deep brain stimulation may be considered to regulate abnormal brain activity.
Understanding the role of dopamine is key to demystifying Parkinson’s disease. It shifts the perspective from visible symptoms to the underlying neurological changes driving them. This awareness not only helps in early identification but also fosters empathy and informed care for those living with the condition.
As research continues, there is hope that deeper insights into dopamine pathways will lead to more effective treatments. Until then, awareness, early diagnosis, and comprehensive management remain the strongest tools in addressing the impact of Parkinson’s disease.
Dr Kunal Bahrani is chairman & group director – Neurology at Yatharth Hospitals.
The opinions expressed in this article are those of the author and do not purport to reflect the opinions or views of THE WEEK.